KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Exchange Rate Effect (2020 - 2024)

Inovio Pharmaceuticals (INO) has disclosed Exchange Rate Effect for 10 consecutive years, with $32403.0 as the latest value for Q1 2024.

  • Quarterly Exchange Rate Effect rose 1789.42% to $32403.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $32403.0 through Dec 2024, up 926.61% year-over-year, with the annual reading at $32403.0 for FY2024, 926.61% up from the prior year.
  • Exchange Rate Effect hit $32403.0 in Q1 2024 for Inovio Pharmaceuticals, up from $483.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $32403.0 in Q1 2024 to a low of -$16563.0 in Q3 2022.
  • Historically, Exchange Rate Effect has averaged -$0.13 across 5 years, with a median of -$1918.0 in 2023.
  • Biggest five-year swings in Exchange Rate Effect: tumbled 696.65% in 2022 and later skyrocketed 1789.42% in 2024.
  • Year by year, Exchange Rate Effect stood at $21021.0 in 2020, then crashed by 134.83% to -$7321.0 in 2021, then surged by 268.65% to $12347.0 in 2022, then plummeted by 96.09% to $483.0 in 2023, then skyrocketed by 6608.7% to $32403.0 in 2024.
  • Business Quant data shows Exchange Rate Effect for INO at $32403.0 in Q1 2024, $483.0 in Q4 2023, and -$2109.0 in Q3 2023.